Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittorio Ferrari

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Pharmacology|August 11, 2017
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic ActivityFrancesca Bedussi, Diego Galli, Martina Fragni, et al.
International Journal of Environmental Research and Public Health|July 29, 2025
Changes in Coping Strategies of Parents and Girls with Central Precocious Puberty Before and After the COVID-19 Lockdown: Data from Four Italian Pediatric Endocrinology CentersMaria E Street, Anna-Mariia Shulhai, Dolores Rollo, et al.
Tumori|April 4, 2013
Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based surveyDiego Cortinovis, Giordano Beretta, Elena Piazza, et al.
Cancer|October 25, 2011
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotideGiordano Savelli, Francesco Bertagna, Fabio Franco, et al.
Journal of Pain and Symptom Management|October 16, 2016
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled TrialErnesto Zecca, Cinzia Brunelli, Paola Bracchi, et al.
ACS Applied Materials & Interfaces|June 3, 2021
High-Pressure Synthesis and Gas-Sensing Tests of 1-D Polymer/Aluminophosphate NanocompositesFrederico G Alabarse, Michelangelo Polisi, Marco Fabbiani, et al.
Clinical Genitourinary Cancer|December 28, 2013
Standard vs adapted sunitinib regimen in elderly patients with metastatic renal cell cancer: results from a large retrospective analysisUgo De Giorgi, Emanuela Scarpi, Cosimo Sacco, et al.
Journal of Geriatric Oncology|February 6, 2014
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancerUgo De Giorgi, Karim Rihawi, Michele Aieta, et al.
Oncology|January 17, 2015
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trialCora N Sternberg, Fabio Calabrò, Sergio Bracarda, et al.
Future Oncology (London, England)|March 20, 2014
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community settingGiuseppe Procopio, Lisa Derosa, Angela Gernone, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Pharmacology|August 11, 2017
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic ActivityFrancesca Bedussi, Diego Galli, Martina Fragni, et al.
International Journal of Environmental Research and Public Health|July 29, 2025
Changes in Coping Strategies of Parents and Girls with Central Precocious Puberty Before and After the COVID-19 Lockdown: Data from Four Italian Pediatric Endocrinology CentersMaria E Street, Anna-Mariia Shulhai, Dolores Rollo, et al.
Tumori|April 4, 2013
Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based surveyDiego Cortinovis, Giordano Beretta, Elena Piazza, et al.
Cancer|October 25, 2011
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotideGiordano Savelli, Francesco Bertagna, Fabio Franco, et al.
Journal of Pain and Symptom Management|October 16, 2016
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled TrialErnesto Zecca, Cinzia Brunelli, Paola Bracchi, et al.
ACS Applied Materials & Interfaces|June 3, 2021
High-Pressure Synthesis and Gas-Sensing Tests of 1-D Polymer/Aluminophosphate NanocompositesFrederico G Alabarse, Michelangelo Polisi, Marco Fabbiani, et al.
Clinical Genitourinary Cancer|December 28, 2013
Standard vs adapted sunitinib regimen in elderly patients with metastatic renal cell cancer: results from a large retrospective analysisUgo De Giorgi, Emanuela Scarpi, Cosimo Sacco, et al.
Journal of Geriatric Oncology|February 6, 2014
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancerUgo De Giorgi, Karim Rihawi, Michele Aieta, et al.
Oncology|January 17, 2015
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trialCora N Sternberg, Fabio Calabrò, Sergio Bracarda, et al.
Future Oncology (London, England)|March 20, 2014
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community settingGiuseppe Procopio, Lisa Derosa, Angela Gernone, et al.
Pageof 8